Stanislaw Rajmund Burzynski, Stanislaw R. Burzynski, Stanislaw Burzynski, Stan R. Burzynski, Stan Burzynski, S. R. BURZYNSKI, S. Burzynski, Arthur Burzynski, Hippocrates Hypocrite Hypocrites Critic Critics Critical HipoCritical
—————————————————————– “Orac” and David H. Gorski, M.D., Ph.D., FACS,
collectively, “GOrac” a/k/a GorskGeek thinks that signs of “Getting Worse is Getting Better” [1]😛
That’s right ! 🙂
I almost couldn’t believe my eyes, but GorskGeek seems to have come around to Burzynski’s way of thinking (according to “Dr.” Bob🙂)
GorskGeek describes it thusly:
—————————————————————– “Conventional cancer treatment can also cause tumors to swell temporarily, due to inflammation”
“A patient who isn’t familiar with this phenomenon may assume her tumor is growing”
“When that swelling subsides, patients may assume it’s because of Burzynski, Adamson says”
“In reality, the tumor was just returning to its previous size”
“Pseudoprogression can be a real confounder in assessing the response of brain tumors to therapy, being observed up to 28% of the time”
—————————————————————–
Here’s how GorskGeek’s“brother” in blatherskite; I’m NOT a doctor, 😷 (but I play one on The Other Burzynski Patient Group), Robert J. (don’t call me “Bobby”) “Bob” Blaskiewicz Blatherskitewicz, describes it [2] 😝:
—————————————————————– 8/27/2012, Monday[2]
“On the 27th, we hear:”
“Firstly, Amelia hasn’t quite been herself unfortunately”
“She has been very reluctant to walk, a lot more tired, slow and pretty lethargic”
“She was sick on Saturday night also”(8/25/2012)
“We are reasonably confident we have probably gone too far with the steroid reduction so we have actually increased these slightly again today”
“We decided we would rather have a happy and more alert Amelia than one who doesn’t want to do too much – so we made this decision today in coordination with the Burzynski clinic“
“We’ll see how she does”
“There is a small chance it is the tumour growing, but much more likely given the scans we have that this is due to swelling of the tumour caused by the treatment”
“Time will tell. […]”
“The symptoms we are seeing right now are a direct result of the tumour, hopefully due to it swelling, and the steroids will fix this”
“They are also what we would see if it has grown”
—————————————————————–
(Below comments by: I’m NOT a doctor, 😷 (but I play one on The Other Burzynski Patient Group), Bob Blaskiewicz 😜)
And here’s another example of something that is…desperately, desperately wrong at the Clinic 😦
The patient is being told that the tumor is swelling because of the treatment 😳
How is it that only at the Burzynski Clinic that getting worse is indistinguishable from getting better?😡
Second point:
this is a tumor on the brainstem
If a possible side effect were swelling of the thing pressing against the brainstem, you’d expect that to be on the informed consent form, right? 😐
The type of thing that would be among the “serious side effects,” right? 😮
—————————————————————–
So, to recap 😄:
—————————————————————— David H. Gorski
• ( “Getting Worse is Getting Better”) 😃
•“Conventional cancer treatment can also cause tumors to swell temporarily, due to inflammation“
—————————————————————– Amelia Saunders
•“ . . . but much more likely given the scans we have that this is due to swelling of the tumour caused by the treatment”
•“The symptoms we are seeing right now are a direct result of the tumour, hopefully due to it swelling . . . ”
—————————————————————– “Dr.” Bob Blaskiewicz (I’m NOT a doctor, 😷 but I play one on The Other Burzynski Patient Group)
• The patient is being told that the tumor is swelling because of the treatment
• How is it that only at the Burzynski Clinic that getting worse is indistinguishable from getting better?
• If a possible side effect were swelling of the thing pressing against the brainstem, you’d expect that to be on the informed consent form, right? “O”
——————————————————————
The problem with this is:
In support of this “phenomenon”, the article provides a link to a Canadian web-site [3] 😶
——————————————————————
The site posits:
—————————————————————— “RT/TMZ is now widely practiced and the standard of care for appropriately selected patients, we are learning more about the consequences of RT/TMZ”
“One phenomena, termed Pseudo-Progression (psPD)…”
——————————————————————
The problem is that this only applies to “Glioblastoma Multiforme (GBM)”, and the article provides NO proof whatsoever, that any of Burzynski’s “Glioblastoma Multiforme (GBM)” patients have taken “RT/TMZ” 😐
——————————————————————
Additionally, the site cites the reference as:
Sanghera, Perry, Sahgal, et al., “Sunnybrook Health Sciences Odette Cancer Centre” (in press, Canadian Journal of Neuroscience)
(“In press” refers to journal articles which have been accepted for publication, but have not yet been published)
However, the journal article in question was published 1/2010, so it has NOT been “in press” for over 3 years and 7 months [4] 😁
Get your act together, aye, CAN-A-DUH! 😇
——————————————————————
☺
😉
—————————————————————–
====================================== Dr. B interview #2
2/7/2013 (10:31)
======================================
Why do you continue to do this ?
Why haven’t you just, given up ?
Because I am right
Why should I stop when I have 100’s of people who are cured
Mhmm
from incurable brain tumors
Ok
We have over 100 people, who are surviving over 5 years, just in the supervised clinical trials with brain tumors
So obviously this works (laughing)
It works in great way
So why should I stop because, some evil people like me to stop ?
It doesn’t make any sense
Evil will lose
So we are right, and we’re going to win
Not, uh, no matter how soon this will be established, but we are going to win
Well, for what it’s worth, and this is something, this is why I wanted to put myself, uh, in front of the camera with you
Obviously I spent 8 months, um, and I’ll try and not get too emotional about it, because that’s unprofessional (laughs)
Yes
but I spent, I spent a long time, looking into this, speaking to people,
Yes
You have very kindly given me access to everything here
Sure
Speak to anyone
Speak to patients
To see medical records, and I have, uh, been amazed by what I, what I’ve seen
I know the statistics are now showing, in the world, that one in two men, will have cancer One in 3 women, will have cancer
Yes
It’s a, it’s a massive problem
That’s right
And I can see that you’ve genuinely found, uh, a cure for cancer
(?)
You know, it might not work for everyone, but if you’re given the su
Yeah
given the support
Yes
If you’re given, uh, the, uh, I don’t know, just the support basically, and the funds maybe, you could really, do some work, that could change, the whole (nature ?)
Absolutely, and then we can get better, and better
Of course, what you have now is not yet the finished products
We understand that
That’s something we can substantially improve
The response rate can be improved
So, certainly, all of this can be done, but, obviously, we need the resources
We need time to do it, and most of my time is spent with such silly thing like, uh, uh, protecting ourselves against attacks from, the people who are hired to destroy us
Ok
Obviously, there are some companies who are working on the payroll of pharmaceutical business, who are trying to smear us
To spread bad publicity about us
To generate lies about us
These people are criminals, and they are still flourishing
The end for them will come soon, but they are still hurting the other people
because the other people will not take treatment
They will not come, and they will die
Ok
There is no cure for, uh, uh, malignant brain tumors which are inoperable, ok, and we can cure at least, good percent of these people
We presented, our results, at many, many, 1st class scientific congresses, like nuero-oncology congresses, cancer congresses, and it’s important for U.K.
I showed you yesterday, eh, presentation on brainstem glioma in children
Yeah, I have it here
and at the same, uh, Congress, in Edinburgh, we presented also another, eh, eh, paper, on the treatment of glioblastoma multiforme, and the survival on, about 88 patients, in glioblastoma multiforme
So obviously, I make, I make this available to everybody , they would like to listen, come to my presentation
They, they, they know about it, but they don’t want to know about it
Why not ?
(laughs) Because they are working
They are slaves of the big pharmaceutical cartels, ok, and on the payroll of big companies
They hate to see somebody else outside, the slavery, who can do it
I’m free man
I can, ah, do the research because, I am spending my own money for it
I don’t need to beg pharmaceutical companies or government to give me the money
I can do it on my own
They hate it
These people
They hate it because they have slave mentality
Mmm
They arch their back for scraps of money from the table, of some powerful companies, from the government, and they, how can you deal with s, slaves
They don’t want to see something new because this would disrupt, slavery system
Ok
So, current medical education s, system is manufacturing robots
They don’t think on their own, they use only what, the government, or the lawyers of the government, or what the administrators will tell them to do, ok, and if they don’t then they get punished, ok (laughs), and that’s a great system for a ph, pharmaceutical companies, because obviously they can make a lot of money, but it’s not a great system for people who have cancer because they don’t have good results
So you’ve presented at these conferences, and people don’t come up to you afterwards and say:
Mhmm
“I want to come and see what you’re doing
I’ve got to see this for myself”
Ah, well, uh, at each of these Congresses I meet a few doctors who are top specialists in their area who will come to me and say: “Ok, this looks very interesting
We’d like to know more about it
Please send me some, eh, results and a few cases that I can review,” and that’s what you do
Yeah
You send them these cases, and that’s the end of it
I don’t hear from them anymore because they’re afraid to move any
Mmm
further, ok, because they know if they move further, they get punished
They don’t receive grants
They’d be scrutinized by their peers
They’re afraid
Ok (laughs)
Yeah
They work for us
Yeah
they work for us undercover
We have over 100 telephone callers who used to work with us, but they don’t want anybody to know about it because they’d be immediately attacked by the other guys
And the pharmaceutical world as well
Ah, well, the other guys are obviously working for cartels
Uh, they’re on the payroll, a, oh, of big business, which is cancer business, and they don’t want to lose it
Uh, in average, uh, city you might have say about 20 oncologists
One of them may work for us, but he does not no, want to tell anybody that he’s doing this because he would be destroyed by the other guys
These 20 guys will jump on him and he will, won’t have practice anymore
Ok
Yeah
So that’s, uh, the travesty, but, uh, uh, I believe that this is coming to the end
Ultimately, su, more and more doctors will learn what we do
Yeah
and more and more patients will benefit, and the breakthrough will come, but before the breakthrough will come, you have the toughest time
Mmm
because, the opposition is mounting the attacks
Whenever we came up with an announcement that was in the 20th century, we have such and such success, you are furiously attacked by the other guys, who are on payroll, uh, of cartels
Ok (laughs), for no apparent reason
You should be congratulated but we are attacked, because they see we are going to win, and they hate to see this because this means they won’t see money anymore for them, ok, or at least they think they won’t, they won’t have their payroll anymore
————————————————————— Dr. Burzynski on publishing (6:18)
—————————————————————
So why does, why does, ev, everyone hide behind this thing of saying about publishing, because that’s the thing you hear all the time
Well, we cannot publish until the time is right (laughs)
Yeah
If you would like to publish the results of, of a 10 year survival, for instance
Mmm
Which we have
Nobody has over 10 year survival in malignant brain tumor, but we do, and if you like to do it right, it takes time to prepare it, and that’s what we do now
What we publish so far
We publish numerous, uh, publications which were, interim reports when we are still continuing clinical trials
Now we are preparing, a number of publications for final reports
Eh, many of my publications were rejected by known publi, by known journals like
Why ?
like Lancet, like JAMA,
like New England Journal of Medicine
Why ?
Because they say: “Sorry, but you didn’t receive enough priority to be published“, and if you look in these journals and 1/2 of the, these journals, they are advertising for pharmaceutical companies
Obviously if this would come from a pharmaceutical company, this would be published on the 1st page
Mhmm
Ok
Because this, you don’t have objectivity with these guys
They are on the payrolls of the big cartels, ok, and again and if you try again to send, oh, oh, my manuscript to good journals, if they reject it, we go on Internet and you describe what are these guys
So then everybody will know, because I have very good evidence
that we tried many times to publish in 1st class journals, and we are always rejected
It’s just, persistent
And not, and not because of lack of scientific knowledge
No, because of lack of priority
And who has priority ?
The guys who are paying money for advertising
Ok
So that’s, unfortunately what I think will end sometime
—————————————————————
And we are now preparing publication, on some of these results
We have already published the results on the technique of very difficult variety of breast cancer, which is triple-negative breast cancer
Now we are preparing another article on the technique of gynecological cancer, which is best series of over 100 patients treated with incurable ovarian cancer, uterine cancer, (?)
So this, has now been prepared for press
Eh, of course, I would like to, give everybody intravenous antineoplastonssee, if they qualified, but, this is limited by the government, because the government limits us to only the patients who are
have brain tumors, but the other patients, they can be treated through this combination of medication which work on the genes Antineoplastonswork on over 100 different genes
That’s why they give us, very good advantage
There are medications that also work on a number of different genes, and we can combine them together, and use them in the right way
So
that’s what we’ll continue to perfect, and that’s, uh, most of our patients
been treated with just combination of targeted medications
————————————————————— The Future (9:00)
—————————————————————
Why do you continue to do this ?
Because you know the truth, and you want to get the truth out there ?
Absolutely, because we understand we on the right track
Somebody has to do it
I was lucky enough to, find out about it
We have evidence that we are right, and, uh, I don’t think, why should I stop if, people that don’t have sufficient knowledge, who are working, on behalf of some big business, would like to stop us
We are right, and we would like to continue to help people, and, uh, that is what is going to happen
Of course, probably the best reason to make a discovery, and let it stay as it is and ask the other people to publish after I die
Yeah
That’s what happened with the discovery of Nicolaus Copernicus, who was my countryman
Eh, his book was published, sss, when he died, and, uh, for good reason, because of such fears for execution of the people who followed him
like
Hmmm
Galileo, Giordano Bruno, that it took the church, uh, only until recently to agree that, uh, they made the error, in the case
Ok
So if you come up with some breakthrough, you have a choice
Keep it quite until the other guys who understand what you do
or try to use it
In my case, I decided to use it, because I would like to, help people, and now that we can save people, so why should I keep quiet, ok, but certainly if, my work won’t get published because it keeps getting rejected by some of the journals, then we wait until I die, and then we let the other guys publish it
So, ok
======================================
====================================== 1/2012 – Sonali Patil, Ph.D., Research Scientist at The Burzynski Clinic (18:22) 9/18/2012
======================================
So you, you, you’re a scientist here ?
I’m a scientist here
And, and you work, just with antineoplastons ?
Not necessarily
This is our cell biology lab, and in molecular biology we do basic research on the antineoplastons
Sometimes we also study it in combination with the other, uh, medicines that Dr. Burzynski is interested in
So, but mostly antineoplaston
This is looking at mechanism for action
Trying to understand how it treats the cancer cells, is able to kill the cancer cells without damaging the other cells of the body
So mostly antineoplaston is the target here
And what do you think about antineoplastons ?
We have found, uh, very interesting, uh, molecular pathways targets that antineoplaston is targeting, working very effectively to kill the cells, um, probably better than many other drugs, because, um, it has multiple targets, and so attacks the cells from many different angles, and is able to kill the cancer cells, more effectively
So, can I ask you, how did you come to work in, th, the Burzynski
the institution ?
Through an advertisement, it was
My position was advertised
I started 8 years ago, and
So ok
So it was advertised
Mhmm
So when you applied for the job, were you aware of the controversy of, (comments to self: learn to talk)
So when, when did you find out ?
Uh, eh, as soon as I joined (laughing)
Oh yeah ?
Few months later
I thought, it’s easy to find
It’s not hard
Of course
It’s not even, uh
Wha, what about any of you other colleagues, that prior to coming here ?
I mean, did they say anything to you, like, you know ?
Well they brought something up
(?) in, uh, uh, being there for him during this trial, my boss, my previous boss was here before me
Uh, so I have a very open picture of it, and it doesn’t bother me
He came up against it and won
Yeah
So that’s a good thing
An, and why do you think, it kinda hasn’t been, kinda lost the word, hasn’t taken off, you know ?
Has the scientific community hasn’t really embraced ?
Well anything that is non-traditional always, you know, takes its own time to get to people
Besides, the traditionalists don’t want it coming out because, uh, it affects, a lot of other things, um, finance, in, in the big Pharma
Right
that is affected by this
So, um, if it, if it were, um, a medicine already with another big company, it probably would already be out in the market by now, but, uh, it’s because it’s one man’s show
He’s fighting against, uh, traditional medicine, big, big centers like M.D. Anderson right here in Houston
So, most people want to believe, uh, what the other doctors, the oncologists, are telling them, because that’s what everybody does
So very few filter out of that and come looking for him, because they’ve lost hope there, and they’ve tried everything else, and they come because; which I wish they wouldn’t, come here as a last resort, you know
Mmm
and, by then, sometimes, uh, enough damage has been done that is sometimes even he cannot cure
It’s not magic
It’s
There’s a logic to the way the medicine works
The science behind it is not, it’s not just a magic bullet
So, and you have to target it at the right time
Catch cancer at the right time
So I have a, friend of my mother’s at home, whose spent, her whole, academic career, 20, 30 years, researching, astrocytomas
Mhmm
And, uh, you know, I did my research, and, I was no doubt that we were coming here
No question
My, my research was more based on people
Excuse me
On people
Talking to people who had been treated, and seeing the results, and then looking at the research afterwards, and she was just saying that “I’ve spent all my years, research, and research, and research, I can’t find anything, that validates, this, this treatment”
Now I’m not asking you to comment on what she said, but,
No, validation, validation basically means, uh, proof in scientific community
If you’re not accepted into the scientific community, you’re not going to be able to present that truth, and we go and present at conferences all the time, eh, when it comes to publishing papers, uh, we haven’t been very successful Dr. Burzynski has published, uh, a lot of data of his patients
So it’s out there
Yeah
If you, if you want to believe it, and you’re looking for it, you’ll find it
Yeah
It’s just, um, it’s not in the mainstream places, because it gets rejected out of there
Um, it’ll probably take some time to get into those spots where everybody else is publishing, and everybody else is talking about it, but it doesn’t mean that it’s not true
So obviously you’re here on a daily basis
So when was the 1st
Last 8years
So the last 8 years
When was the 1st time you actually saw, was it in the dish where you actually saw it ?
Well we see it, we’ve seen it for years before I came here
Yeah, but when was the 1st time you saw it, when you came here yourself and you saw ?
Well we see it every day
Um, we have cancer cells in the lab, that we treat, with the medicine
We see them dying
We see them undergoing a necrosis, which is the cancer deaths, pathway, that most people study and talk about
So
So, it’s happening, it’s happening in front of our eyes everyday
So, we have proof for it
you know (?)
We just have to get it out there, and there’s a, there’s a system to all that
Um
and were trying to, get it through the system, and get it out there
So what, when you 1st realized there is something here, did you not just feel like just shouting from the rooftops and telling everybody?
Well I wasn’t the one who discovered
He did, in the ’80’s
Yeah
and since then he’s been shouting from the rooftop
It’s just, nobody would listen to him
Yeah, yeah
So, you know, we’re just doing the, uh, actually it’s backwards
People usually do, uh, pre-clinical research 1st, because the medicine
Mhmm
goes out and to the patients, and we, we are kind of doing it, the other way around
He already has patient data
He’s been treating people
on this
People, survivors walking around, to tell the story, and now we are being made to understand how it works in the cells
So, it’s, it’s kinda doing, the research, after the trials
Just tell me
One more question
What’s it like
How would you describe Dr. Burzynski?
I admire his, uh, passion, for what he does
He truly believes in what he does, and to me that’s, that’s a big thing
If you don’t believe in yourself, then nobody else will, and, his memory
He, he has tremendous memory, and, uh, uh, quick thinking
He’s able to piece together stuff, uh, research articles, papers, put together puzzle, come up with a theory
He does that every day, every time I meet him it’s, it’s interesting to me to see how his brain works
you say, in, in the purest sense, he’s a scientist
I think he’s a doctor 1st, but a doctor who’s very, very interested in science, and that’s an important thing, because a lot of, uh, doctors don’t care about the research, and he does
I think, I think his primary aim is to treat patients, mostly
So if there were any type of skeptic, research scientist out there, what would you say to them about what goes on here?
We do, we do, everything that happens in any other lab, anywhere else
I went to school at Houston, ah, so, I know exactly how the labs work
We do exactly what they do
Yeah
Um, we try to write up our papers, and send them to the journals, just like everybody else does
Uh, present at conferences
We try to get our data out there
Um, we’re trying to do our best, just the way everyone else is
I, I suppise trying to do your best it, it, it’s fascinating because you actually have something
Yeah
that really, really does work
Mhmm
I mean, it’s a cure, right ?
We believe it is
It’s a cure for cancer
Not for all cancers
I actually asked Dr. Burzynski
Mhmm
I filmed him the other day and said to him, why do you, specialize in brain tumors ?
Mhmm
Do you know what his answer was ?
What was it ?
He said it’s because it’s the most difficult type of cancer
Well it is if, if you think about it
I don’t think there are many doctors who claim to have survivors, eh, at least in the numbers that he has, to present
Yeah
and, um, I hear that at conferences too when we, were standing around, they will look at the slides, eh, eh, which is a tumor, and they will say: “Well that’s not a tumor,” ye, “it’s just necrosis
It’s just a patch on the skin, and you just cured nothing, and”, uh, all the, “the patient was probably cured from, the therapy that he took elsewhere, you know, the radiation he got 10 years ago”
“That’s probably what cured him,” but, you know, th, those kind of patients will be rejected from other, hospitals, don’t survive, that far enough to, to tell a story
So what is it ?
Just people living in denial ?
Is it fear ?
Is it ?
Fear or denial
I’m going to do what everybody else does
Why, why should I go out and do something different, here ?
Yeah (?)
And, and lastly, you know the, the power the pharmaceutical companies have
Well of course
I mean, but I’m nobody to, comment about that
Yeah, yeah
You know
There’s, there’s a lot going on behind the scenes that we are not even aware of, but this is just what, um, my experience is, when I talk to other doctors at meetings and conferences, and they, you’re immediately dismissed as, oh, you know: “What you’re going to say doesn’t really make any sense because you work for, Dr.”
His name has been tarnished
——————————————————————
There’s a lot more, to that, than just, people playing politics, this, this, a whole lot of stuff going on behind there
So, I don’t think it’s, it’s (supression ?) as much, it’s just trying to tell your story, uh, so that somebody would listen and accept it, uh, maybe using, the right channels, going, presenting it in a different way, make it more convincing
All that, would help
So if it, if it was you, in his position, would you not have just given up ?
Or would you
Oh, definitely
We all talk about it all the time, that the amount of determination that he has, most people, would back off and leave, but like I said, he believes in what he does, and that’s what keeps him going
Yeah
As far as publishing is concerned, ’cause a lot of scientist want to see
We’ve tried
We, we, don’t get past the initial screening
We repeatedly send it back to other journals and that’s the process I keep doing all the time
Comes back, I send it back to another journal
Hopefully, one day it will get it
So, let, let, let, let me get this straight, ok ?
You write articles, right ?
Papers
Papers
Mhmm
and you submit them to, medical journals
Mhmm
and then what happens ?
They come back
Why do they come back ?
Sometimes, um, if they get to reviewers, uh, it’s not enough data, or, which I understand
We can work on changing, modifying papers, but, many times they come back, without any reason
They just get rejected, at the 1st, screen itself
So they come back without any reason
And why do you feel that is, in your own humble opinion ?
Wha ? (laughing) not humble opinion
It’s, it’s hard, um, publishing is a tricky game, you know ?
You have to publish once, to get your name in there, and then, they might publish you again, but, uh, with the negative publicity that we already had, and most of the community would look at the name and say: “Oh we, we just don’t want to, want to even read it”
So, it, it doesn’t even get past the 1st screen, because they don’t turn, flip the 1st page even
Ok, so, what you’re saying is that you see things that are published in these journals
Oh yes
And, you see ?
very similar stuff
We try to, we try to do research that is on par, uh, with what everybody else is doing, as far as the techniques, the ana, the data analysis
We, we try to do everything which is the standard for, uh, the research community, but, doesn’t get past
Um, how frustrating must that be for you ?
Mmm, it is (laughing), it is
So do you feel like you’re a party, or you’re trying to get into a party, and knocking on the door, and no one’s letting you in ?
I feel like that at the conferences too because, um, sometimes they come up to your, poster presentations, and, um, they’ll ridicule you right there, while you’re standing there by your presentation
Ok, just last thing, because one of the things I heard
Mhmm
recently, which were, that, uh, there’s some evidence that Dr. Burzynski has from, from the phase 2 clinical trials, showing people who have, uh, glioblastomas who’ve been alive for 10 years
Mhmm
and there’s something there that they want to try and get published
Mhmm
What you’re saying is, that might never get published ?
Well, Dr. Burzynski’s case is different
He has published some of his patient data
I’m talking about the research, uh, the pre-clinical research, the cell culture data, the molecular data
Um, we haven’t had success getting that out, but, he has, he also faces rejection a lot, but he doe, he has managed to get ta, a few publications in
So how does it work ?
If, if you submit something they can
What’s the process ?
They can submit it back ?
That’s not, there’s a review
There’s a whole review board
Um, you can select your reviewers
It goes through couple of cycles of review before it’s, agreed that they will publish it
So,
And in case they say no to publishing it
You can
do you, can you take it somewhere else ?
Yeah, you can take it somewhere else, but, um, but it’s, the peer-reviewed journals that are the ones that you want to get into, you can publish whatever you want, ah, that doesn’t count
That’s why when, somebody who’s of, uh, any significance in science would not even look at those articles if they’re not in a peer-review journal
So, they have to get into a decent place to make a mark
Do you think that will happen ?
What do you think has to happen in order for ?
It’ll happen, in, in time
They can’t keep refusing you
We, we try again and again
——————————————————————
But in time they just want to, not focus on it, and just have’m, bring in more numbers, and keep doing this, and in the meantime keep treating, some number of patients
On, on, top of everything, my personal belief is, uh, brain tumors are not, uh, a money-raising factor, because it’s a, it’s a minority cancer
If this were treating, uh, mainstream cancers as they’re called, as, uh, breast cancer, maybe they would look at it more seriously, but the numbers, with the brain tumors, which is a good thing
I mean it’s a deadly cancer
You don’t want more people to have it, but, that puts it in the category of, um, you know, not so feasible, as far as the money-making
And so, the priority; even though, it’s the most vicious, and it should be looked at more seriously, but, it’s not the one that brings the big bucks
So
So, put it aside
So why would the FDA, haven’t closed him down then ?
Because they, they, uh, believe the data that he’s sending them so far, and they don’t have a valid point to, just say no, it doesn’t work, and put it away
They see effect, and so they want, more numbers, more data
Is it, it the phase 2 trial is finished ?
Mhmm
but they’re still accepting people ?
Yeah
on more like a special ?
Special basis, and, um, sometimes compassionate grounds
(compassion exception)
Uh, exceptions
That’s normal ?
Yes
So
(Yes I guess it is a funding issue ?)
Right
(Like FDA, during the 2nd phase of clinical trials they found the data to be, real, real one, and they gave him the ok to go for 3rd phase of clinical trials, but just to go through this process you would probably need $100,000)
(?) and that’s stalling
(even more, millions dol, millions of dollars, to go through the 3rd phase of clinical trials, and)
(?)
(he’s a single doctor
It’s a 1st case)
Yeah
(probably in American history)
It is
(that single doctor is trying, to get a his job)
Self-funded
(approval
Self-funded
Whatever you’ve seen on that plant, everything came out of his practice
So he was the one who funded, literally the, the, research and development phase, but those installation, operation, all this big plant was built ?)
Yes, ’cause, uh,
(private)
one of the things I hear a lot, I’ve heard slot in the U.K. is that: “Why is he charging people for clinical trials ?
Well, uh, how else would you run this place ?
Exactly
How will you run this place, and how else will people be on the trial, because
Right
you know, there’s no pharmaceutical company involved here, right ?
There’s nothing
Nothing
It’s all out of his pocket
Every single bit
So
And what is stalling (?) is (?) again is, is funds
Money
Yeah, I also heard that the phase 3 they wanna do radiotherapy with, with it
Mmm
Hopefully, that will not be the case, but
we’re trying to
I think, uh, he is trying to fight against that, but, the FDA is the FDA, so
And what do you think about this case, he’s now got coming up in April ?
You know, he’s got this court case
Well there’s always something
Yeah (laughing)
He, he’s won before, so
Yeah
Do you think he needs the support, do you think he feels the support from, from all of you ?
I think so, for sure
(Oh, absolutely)
Yeah
Nobody forced us to work here
(Ah-hah)
Yeah
We get paid, but, you know
I could always look for another job if I needed to (laugh)
Yeah
So would you stay here because you really believe in what’s going on here ?
(?)
(Yes, that’s one thing that’s unique about our operation, and I’m talking about this location is, uh, whoever joined the company; and we have a guys who joined the company in the 80’s, 90’s
They stay with the company
Turnover is zero)
Yeah
(Joined the company
Stays with the company
It’s a challenge)
Yeah
(It’s a (?) challenge for us)
======================================
[1] – September 28, 2013 “The Skeptics™” Burzynski discussion: By Bob Blaskiewicz – 2:19:51
====================================== BB – Bob Blaskiewicz
—————————————————————— DJT – Didymus Judas Thomas
====================================== 0:47:00
—————————————————————— BB – “Ummm, o-kay”
“Uh, I want to turn this over to the people who are watching”
“Um, I want to give them a a chance to address you as well”
“Uhmmm, hi everyone”
—————————————————————— 0:48:00
—————————————————————— 0:53:00
—————————————————————— BB – “A every time that I and and and and, and David (James @StortSkeptic the Skeptic Canary) points this out, that um, you you know you’re not going to speculate about the the FDA but then at every turn you’re invoking the FDA as being obstructionist“
—————————————————————— 0:54:02
—————————————————————— BB – “I, I just find that to be contradictory and and self-defeating“
====================================== DJT – Bob, exactly where did I invoke “the FDA as being obstructionist” ?
====================================== 1:02:00
—————————————————————— BB – “Um, it’s it’s it’s not the FDA’s, but you understand it’s not the FDA’s job to tell someone that their drug doesn’t work“
—————————————————————— 1:03:00
—————————————————————— BB – “it’s it’s it’s up to Burzynski“
“It’s up to Burzynski to show that his drug does work”
“And it’s always been his burden of proof“
“He’s the one that’s been claiming this miracle cancer cure, forever”
====================================== DJT – Bob, Burzynski showed and proved what he needed to prove to the FDA in order to do phase 2 clinical trials, 9/3/2004 – FDA granted “orphan drug designation” (“ODD”) for Antineoplastons (A10 & AS2-1 Antineoplaston) for treatment of patients with brain stem glioma, .10/30/2008 – FDA granted “orphan drug designation” (“ODD”) for Antineoplastons (A10 and AS2-1 Antineoplaston) for treatment of gliomas, and FDA approved phase 3 [1-2]
Oh, and Bob, exactly when did Burzynski 1st claim “this miracle cancer cure” ?
====================================== 1:04:02
—————————————————————— BB – “Um, that we’d love to see, however we can’t see, however we can’t see it because of proti protri proprietary uh protections that the FDA is giving to Burzynski, right ?”
“They’re not sharing his trial designs because they are his trial designs, right ?”
“That the makeup of his drug that he’s distributing are his, uh design, and his intellectual property“
“So the FDA is protecting him, uh from outside scrutiny“
====================================== DJT – Bob, you make it sound like it’s part of some grand “conspiracy” between Burzynski and the FDA to keep information from “The Skeptics™” [3]
——————————————————————
21CFR601
Subpart F–Confidentiality of Information
Sec. 601.50
Confidentiality of data and information in an investigational new drug notice for a biological product
(a) The existence of an IND notice for a biological product will not be disclosed by the Food and Drug Administration unless it has previously been publicly disclosed or acknowledged
====================================== BB – “While you may imagine that that, that that the FDA is is somehow antagonistic toward him“
“They’ve given him every opportunity, over 60 opportunities to prove himself worth uh their confidence and hasn’t“
====================================== DJT – Bob, that certainly explains the 9/3/2004 and .10/30/2008 ODD’s and phase 3 clinical trial approvals by the FDA – NOT [1-2]
====================================== 1:05:00
—————————————————————— 1:42:00
—————————————————————— BB – “I don’t, the thing is though that, that that’s a inver, shifting the burden of proof off of Burzynski”
“Burzynski has to prove them wrong, has to prove him right”
“The FDA is not there to say this doesn’t work”
====================================== DJT – Bob, who initiated and put into place the clinical trial hold ?
Burzynski ?
FDA ?
Both ?
====================================== 1:43:30
—————————————————————— BB – “So, I mean, honestly, um, saying “Well, when the F, FDA tells you that it doesn’t work, the FDA’s never gonna say that because that’s not their job“
—————————————————————— 1:44:00
—————————————————————— BB – “That’s not an option, because they’re never gonna do it“
“They relinquish, a lot of authority, over to Burzynski, and his Institutional Review Board, which, I would mention, has failed 3 reviews in a row” ====================================== Bob, where are the “final reports” for those “3 reviews” ? ====================================== BB – “Right ?”
“It is Burzynski’s job to be convincing”
“It is not our uh, uh, it it it he hasn’t produced in decades“
“In decades”
“In hundreds and hundreds of patients, who’ve payed to be on this”
“Hell, we’d we’d we’d like a prelim, well when you’re talking about something that is so difficult as brainstem glioma, that type of thing gets, really does in the publishing stream get fast-tracked there”
====================================== DJT – Bob, Burzynski has provided numerous phase 2 clinical trial preliminary reports, which our #fave oncologist has chosen to ignore [4]
====================================== BB – “they test it”
“Yeah, and they they they want uh, that was evidence of fast-tracking is what, that rejection was uh e was very quickly“
====================================== DJT – Bob, have you checked The Lancet Oncology [5] to see what was so much more important than Burzynski’s “phase 2 clinical trial Progression-Free Survival (PFS) and Overall Survival (OS) re patients 8 – 16 years after diagnosis, results” [6] and the Japanese antineoplaston study ? [7]
====================================== BB – “So, how long will it be before Burzynski doesn’t publish, that you decide that uh perhaps he’s he‘s, doesn’t have the goods ?“
“Um, so, uh, uh again, the FDA is not the arbiter of this“
“It’s ultimately Burzynski”
“You’ve been speculating about what the FDA’s motivation are like crazy”
“Why not speculate about Burzynski a little bit”
====================================== DJT – Well, how have I been speculating ?
====================================== 1:46:00
—————————————————————— BB – “Well actually I’m not even asking you to speculate about Burzynski, I’m only asking you to tell me, how long would it take, uh how, for him to go unpublished like this, um, for this long, before you would doubt it ?” ====================================== DJT – Note how, above, without proving it, Bob claimed “at every turn you’re invoking the FDA as being obstructionist”, and now, directly above, again, without proving it, Bob claims “You’ve been speculating about what the FDA’s motivation are like crazy” —————————————————————— DJT – what the journals keep saying, in response
====================================== BB – “What ?”
====================================== DJT – You know, are they going to give The Lancet response, like they did in 2 hours and such, saying, “Well, we think your message would be best heard elsewhere,”or they gonna gonna give The Lancet response of, “Well, we don’t have room in our publication this time, well, because we’re full up, so, try and pick another place”?
====================================== BB – “But these but but but that doesn’t have any bearing on“
“That doesn’t”
“Oh I’m not asking you how long, how long, would it take you for you to start doubting whether or not he has the goods ?“
“How long would it take ?”
“It’s a it’s a it’s a question that should be answered by a number uh uh months ?“
“Years ?”
“How long ?”
“It’s been 15 years already”
====================================== DJT – Well, you like to jump up and down with the “15 year” quote, but then again I always get back to, Hey, it’s when, when the report, when the clinical trial is done
—————————————————————— 1:47:06
—————————————————————— DJT – Not that he’s been practicing medicine medicine for 36 years, or whatever, it’s when the clin, clinical trial was done
====================================== BB – “I could push it back to 36 years”
“He hasn’t shown that it works for 36 years”
“I can do that”
“I was being nice” ====================================== DJT – Note how Bob acts like he’s been hit with “The Stupid Stick”
If he wants to go back “36 years”, I can refer back to 1991 (11/15/1991) – Michael J. Hawkins, M.D., Chief, Investigational Drug Branch, Department of Health &Human Services (HHS), Public Health Service, National Institutes of Health (NIH), National Cancer Institute (NCI), sent a 1 page Memorandum Re:
Antineoplaston to Decision Network, which advised, in part:
“It was the opinion of the site visit team that antitumor activity was documented in this best case series and that the conduct of Phase II trials was indicated to determine the response rate”[8] —————————————————————— DJT – The FDA A believes there is evidence of efficacy
====================================== BB – “Perhaps based on bad phase 2”
====================================== DJT – Well, we don’t know that
We don’t have the Freedom of Information Act information —————————————————————— DJT – Remember, Bob is the one who told me during the 9/28/2013 Google+ Burzynski Discussion Hangout:
“You’re you’re you’re assuming”
“You’re you’re you’re assuming that”
“You’re assuming that”
“Um, I’m not assuming that”
“There is a correct answer here”
“You don’t know”
“You don’t know”
“You need to look into it”
“Alright ?”
“Before you dismiss it you have to look into it”
“Everytime somebody throws uh uh something to me, I have to look into it”
“That’s just, it’s my responsibility as a reader”
“T t and what I would honestly expect and hope, is that you would be honest about this, to yourself, and and and that’s the thing we don’t, we often don’t realize that we’re not being honest with ourself“
“I try to fight against it, constantly”
Bob just ASSUMED that the FDA approved phase 3 clinical trials for Burzynski “Perhaps based on bad phase 2”, but tells me NOT to ASSUME ? ====================================== BB – “He withdrew”
“He withdrew the the phase 3 clinical trial”
“I that before recruiting,
although I’ve seen lots of people say they were on a phase 3 clinical trial“
“I wonder how that happened”
====================================== DJT – Well, we know what happened in the movie because Eric particularly covered that when they tried to get what, what, was it 200 or 300 something institutions to take on a phase 3, and they refused
====================================== 1:48:01
—————————————————————— BB – “Uh did do do you think that if they thought that he was a real doctor that they all would have refused like that ?“
====================================== DJT – Well, Eric gave the reasons that they said they would not take a particular uh phase 3
And so using that excuse that you you just gave there, I’m not even gonna buy that one, because that’s not one of the reasons —————————————————————— Note how Bob pulls out the old “if they thought that he was a real doctor” line ?
Is Bob now claiming that Burzynski is NOT even a “real doctor” ? ====================================== BB – “He’s changed things”
====================================== DJT – Eric said they gave
====================================== BB – “That The Lancet is a top-tier journal like New England Journal of Medicine“
“It’s basically be, besieged by uh 100′s of people submitting their, their, their reports”
“Um, it’s just, you know, let’s say he, someone has such a thin publishing record as Burzynski does, do you think that it’s likely that he will ever get in a top-tier journal ?“
“What about the the Public Library of Science?”
“It’s not the only journal there”
“What about BMC Cancer ?”
“There’s lots of places that he can go”
====================================== DJT – We’ll I’m
====================================== BB – “Um, and he doesn’t seem to to have evailed himself of that, as far as I can tell“
“And I would know because he’d get rejected, or he’d be crowing, you know”
—————————————————————— 1:49:02
—————————————————————— BB – “Either way, he’s gonna tell us what happens”
“He told us what happened with The Lancet, you know”
“I don’t have any evidence that suggests to me that he’s even trying” ====================================== Note how Bob refers to Burzynski’s numerous publications as “such a thin publishing record”
Bob, do I need to count all of these for you ? [9] —————————————————————— DJT – Well, I’m, I’m sure that they’re going to keep you appraised just like they have in the past, just like Eric has done in the past
So
I mean, we’ll see what happens with the Japanese study [7]
====================================== BB – “So let’s go back to this”
“How long will it take ?”
“How long will it take before you, the Japanese study’s interesting too because we should be able to find that in the Japanese science databases, and we can find, we can’t find it at all“
“We can’t find it anywhere”
“And, and those are in English, so it’s not a language problem“
“We can’t find that anywhere”
“We’ve asked”
“We asked Rick Schiff, for, for that study”
“And, and it hasn’t come to us“
“He is now I believe on the Board of Directors, over there”
—————————————————————— 1:50:00
—————————————————————— BB – “He should have access to this”
“We can’t get it”
====================================== Bob, did you ask:
1. Annals of Oncology 2010;21:viii221 ?
2. European Society for Medical Oncology (ESMO), Colorectal cancer, Abstract: 3558, May 17, 2010 ?
3. Colorectal Cancer Association of Canada, COLORECTAL CANCER RESEARCH, Month Ending June 19, 2009
11. Antineoplaston Therapy Doubles 5-Year Survival Rate Following Curative Resection of Hepatic Mets (May 27/09) pg. 5 of 20 ?
4. Kurume University School of Medicine (Japan) Department of Surgery ?
5. Hideaki Tsuda ? [7]
====================================== BB – “How how long will it take before you recognize that, nothing is forthcoming ?”
“How long would that take ?”
====================================== DJT – Well that’s like me asking “How long is it going to take for y’all’s, y’all‘s Skeptics to respond to my questions ?”
Because y’all haven’t been forthcoming
====================================== BB – “Well, I mean, were talking about a blog here“
“We’re talking about life”
“No, we’re talking about a blogger’s feelings in that case“
“In in this case we’re talking about, 1,000′s of patients, over the course of of of generations, you know”
“This is important stuff”
“This is not eh eh equating what’s happening to to patients with what’s happening to you is is completely off-kilter as far as I can tell“
“It’s nothing”
“It’s nothing like you not getting to say something on my web-site”
“You know”
“This is they they have thrown in with Burzynski, and they’ve trusted him, and he’s produced nothing“
“Nothing of substance”
—————————————————————— 1:51:00
—————————————————————— BB – “Nothing that that has made all of that um, uh, n nothing th th th that uh his peers would take seriously”
“The other thing that that that strikes me now is that, you know, you you you you keep saying that, well Eric is going to to share things with you”
“Does it ever concern you eh uh eh occur to you that Eric might not be reliable ?” ====================================== Bob, do you want to have a contest to determine which of you is more “reliable” ? ====================================== DJT – Well, he gave you The Lancet information and he posted the e-mail in the movie, and Josephine Jones posted a copy of it [6]
====================================== BB – “He then, and then he”
“And then he he, you know, the the the the dialogue that sprung up around that was, well see, he’s never going to get to get published”
“Well you’re just setting yourself up for wish fulfillment”
“You want him to be, persecuted, so you are ecstatic when he doesn’t get to publish, which is unfortunate for all the cancer patients, who really thought that one day, all the studies were going to be published”
—————————————————————— 1:52:00
====================================== DJT – Well, y’all are free to, you know, claim that all you want, because I don’t always agree with Eric, and uh, he’s free to express his opinion
====================================== BB – “Where has Eric been wrong ?”
====================================== DJT – Well I don’t necessarily believe, what Eric would say about, you know, The Lancet that refused to publish the 2nd one, for the reasons he stated, and which y’all have commented on, including Gorski
You know, I don’t necessarily agree with that
I am more agreeable to y’all, saying that, you know, they’re busy, they’ve got other things to do, but I’m kind of still laughing at their 1st response which he showed in the movie about how they felt about, you know his results would be better in some other publication
I thought that was kind of a ridiculous response to give someone
====================================== BB – “It’s it’s it’s it’s a form letter“
“You know”
“They’re just saying, “No thanks””
““Thanks, but no thanks” is what they were saying, in the most generic way possible”
“Like I said, they’re besieged by researchers trying to publish“
—————————————————————— 1:53:05
====================================== DJT – Well you would think that if its a form letter they would use the same form that they used the 2nd time
You know, they didn’t use the same wording that they used the 1st time
I would have think that, you know, their 2nd comment
====================================== BB – “So, so, possibly”
“So possibly what you are saying is that they in fact have read it, and after having read it they’ve rejected it”
“Is that what you’re saying ?”
“Because that’s what peer-review is”
====================================== DJT – Nah, I’m not saying that they did that all
I’m just sayin’, you know, that they gave, 2 different responses, and I would think that the 2nd one they gave
====================================== BB – “Do you know it was the same editor, that it came from the same desk ?”
“You can’t make that assumption that that the form letter will be the same form letter every time”
“I mean you just can’t“
“I mean in in some ways we have a lot of non-information that you’re filling in, with what you expect, as as opposed to what’s actually really there, and I I I just think you’re putting too much uh stock in one uh, uh, in in in in this uh the publication kerfuffle“
—————————————————————— 1:54:16
—————————————————————— BB – “Um”
====================================== DJT – Well I find it funny, something along the lines of, you know, “We believe your message would be received better elsewhere, you know
I don’t see that as a normal response, a scientific publication would send to someone trying to publish something
I mean, to me that sounds, like, if you’re doing that, and you’re The Lancet Oncology, maybe you need to set some different procedures in place, ‘cuz you would think that with such a great scientific peer-reviewed magazine, that they would have structured things in as far as how they do their operations
====================================== BB – “Well, not necessarily“
“I’ve been in any # of professional groups where the organization is just not optimal, and publications certainly th there are all sorts of pressures from all sorts of different places”
—————————————————————— 1:55:08
—————————————————————— BB – “I I have no problems whatsoever with seeing that this might not be completely uh um uh streamlining uniform processes as possible“
“The fact that it’s not uniform, doesn’t have anything to do with Burzynski not publishing, not producing good data”
“Not just going to a, you know, god, even if, even if, let’s put it this way, even if he went to a pay to play type publication where you have to pay in order to get your manuscript accepted; and he has the money to do this, it wouldn’t take that much, and he were to put out a good protocol, and he were to show us his data, and he would make his, his his stuff accessible to us, then we could validate it, then we could look at it and say, “Yeah, this is good,” or “No, this is the problem, you have to go back and you have to fix this””
“Right ?”
“So we really, every time we talk about the letter that he got, yeah that doesn’t have much to do with anything, really”
—————————————————————— 1:56:02
—————————————————————— BB – “We wanna see the frickin’ data”
“And if he had a cure for some cancers that otherwise don’t have reliable treatments, he has an obligation to get that out there anyway he can“
“And if if peer-review doesn’t, you know, play a, if peer-review can’t do it, you know, isn’t fast enough for him, then he should take it to the web, and he should send copies out to every pediatric, uh, you know, oncologist that there is“
“That’s the way to do it”
====================================== DJT – Well, I’m sure, I’m sure Gorski would have a comment about that, as he’s commented previously about how he thinks uh Burzynskishould publish
====================================== 1:57:10
—————————————————————— BB – “It’s the, it’s the data itself“
“If if Burzynski is is, is confident in his data, he will put it out there“
“Right ?”
“One way or the other”
====================================== DJT – Like I said before
Like I said before on my blog, you know, even if Burzynski publishes his phase 2 information, Gorski can just jump up and down and say, “Well, that just shows evidence of efficacy, you know, it’s not phase 3, so it doesn’t really prove it”
—————————————————————— 1:58:04
—————————————————————— DJT – So then he can go on, you know, for however many years he wants to
====================================== 2:01:00
—————————————————————— BB – “Um, almost no treatment goes out without trials“
“Massive amounts of data are required” ====================================== Bob, do you think that’s the 2.5 million pages of clinical trial data that Fabio said Burzynski sent to the FDA ? [10] ====================================== 2:02:00
—————————————————————— BB – “Uh, in in in that sense, you know, uh all the the the, you know, kind of back-peddling and and and trying to defend him is is going to, not going to help his case at all“
====================================== Bob, exactly where did I exhibit any “kind of back-peddling” ?
====================================== 2:03:03
——————————————————————
BB – “You are, honestly as far as I can tell you are doing the um, you know, you’re you’re ah throwing up uh, uh, uh, you’re giving me another uh invisible dragon in the garage, um”
====================================== DJT – Well y’all, y’all can call things what y’all want
I mean, y’all can give these, fallacy arguments and all that garbage that y’all like, because that’s what y’all like to talk about instead of dealing with the issues
I mean, Gorski doesn’t want to deal with the issues
====================================== 2:04:11
—————————————————————— BB – “Okay, so”
“What you’re telling me is that you trust the FDA to to be able to tell you when he’s not doing, good science, but also that you don’t trust the FDA”
“Do you see an inherent conflict there ?”
====================================== DJT – How did I say I, I didn’t trust them ?
====================================== BB – “Well, when I, whenever I would ask about, like, why would these trials aren’t happening uh and, you know, you say well the the FDA’s arranged it“
“The FDA’s in control”
“They sign off on these things”
“But they’re they’re they’re they’re at the same that they’re, they’re trustworthy they’re also not trustworthy depending on what you need for the particular argument at the time“
—————————————————————— 2:05:12
—————————————————————— BB – “You’re suggesting that they’re untrustworthy”
====================================== DJT – No, I’m just sayin’ that I’ve raised questions and none of The Skeptics wanna to uh talk about ‘em [11]
====================================== BB – “Do you know that the FDA pulled out of the prosecution ?”
“Did you know that the FDA pulled out of the prosecution um of his criminal case, because they were backing a researcher ?” ====================================== Bob, would that “researcher” be Dvorit D. Samid, who was in Burzynski: Cancer is Serious Business (Part I) ? —————————————————————— DJT – Well, we know a lot stuff they did, but that still doesn’t impress me that they pulled out of the prosecution
I mean
====================================== BB – “Yeah, the the the it wasn’t the FDA who was pressing charges, it was a Federal prosecutor“
====================================== DJT – Right
====================================== BB – “Right”
“And and, they declined to provide information that the prosecution needed“
“That’s important”
“That that that’s really important“
“That he has been given the benefit of the doubt, and he has come up wanting, for decades now”
====================================== DJT – Well I find it interesting a lot of this uh, a lot of these letters that were provided between, you know, the government and Burzynski, when the uh phase 2 study was going on, at the behest of the NCI
You know, anybody who reads that stuff knows, that when you just ignore the person that’s been doing, do treating their patients for 20 something years, or close to 20 years, and you change the protocol without his approval, and you don’t use the drugs in the manner that he knows works
====================================== 2:10:15
—————————————————————— BB – “One of the interesting things about Doubting Thomas that I think you should definitely consider for yourself, is that at some point, when faced with the real opportunity to prove or disprove his assertions, he doubted himself”
“And that’s important”
“And that’s where you’re falling short in the analogy”
====================================== DJT – Well, I think The Skeptics, Skeptics are falling short because, you know, they don’t own up to
====================================== BB – “I’ve laid out exactly what it would take for me to turn on a fucking dime”
“I have, I have made it abundantly clear what I need“
“Gorski has made it abundantly clear”
“Everybody else, Guy, and David, and Josephine Jones, uh, the Morgans, all of them have made it abundantly clear, what it would take to change our minds, and you’ve never done that”
—————————————————————— 2:11:02
—————————————————————— BB – “And even in this, this was an opportunity to do that“
“To come up with a basis for understanding, where it’s like, you know what, If we can show this, you know, if we can show a this guy, that, that, there, that his standards are not being met, then, you know, we could possibly have some sort of ongoing dialogue after this”
====================================== DJT – So I can say that since the Mayo Clinic (Correction: M.D. Anderson) finished their study in 2006, and it took them until 2013, to actually publish it, then I can say, well, Burzynski finished his in 2009, which was 3 years later, which would give Burzynski until 2016
====================================== BB – “Why wasn’t that study”
====================================== DJT – for me to make up my mind (laughing)
====================================== BB – “Why wasn’t that, that that that, still . . again, it it doesn’t seem really to to approach the the the, main question here“
“You know, um . . what are the standards that you have that it isn’t, what are your standards to show that it isn’t efficacious ?“
—————————————————————— 2:12:05
====================================== DJT – Well I can say, well I’m going to have to wait, the same amount of time I had to wait for Mayo (Correction: M.D. Anderson) to publish their study; which was from 2006 to 2013
====================================== BB – “Why was the Mayo”
“Why was the Mayo (Correction: M.D. Anderson) study delayed ?” ====================================== Note how Bob ASSUMES that the publishing of the final results of the M.D. Anderson study were delayed —————————————————————— DJT – How do you know it was delayed ?
====================================== BB – “Well you said you had so many years before you finish it and go in”
====================================== DJT – I mean, has anybody
====================================== BB – “Why, why did it take so long ?“
====================================== DJT – done a review of when a clinical trial is studied, and completed, and how long it took the people to publish it ?
You know
If they could point to me a study that’s done that, and say, well here’s the high end, here’s the low end of the spectrum, here’s the middle
====================================== BB – “I have something for you, okay ?”
“Send me that”
“Could you send me that study the way that it was published because um, just just send me the final study, um, to my e-mail address”
====================================== DJT – Sure
====================================== BB – “Um, because, I can ask that question of those researchers, why was this study in this time, and what happened in-between”
—————————————————————— 2:13:03
—————————————————————— BB – “Why did it take so long for it, for it to come out”
====================================== DJT – Sure, but that’s not gonna, you know like, answer an overall question of, you know, somebody did a comparative study of all clinical trials, and, when they were finished, and at, and when the study was actually published afterwards
You know, that’s only gonna be one, particular clinical study
====================================== BB – “Right”
“Um, but it it would, perhaps, answer the question; because you’re using it as an example on the basis of which to dismiss criticism, whether or not, uh, it is the standard, and therefor you’re allowed to accept that Burzynski hasn’t published until 2016, or, um, it’s an anomaly, which is also a possibility, that most stuff comes out more quickly“
====================================== DJT – Well, we know that the Declaration of Helsinki doesn’t even give a standard saying, “You must publish within x amount of years,” you know ?
So, I’ve yet to find a Skeptic who posted something that said, “Here are the standards, published here”
====================================== 2:14:07
—————————————————————— BB – “I I, yeah, the other thing that David James points out is you know, why 2016 when he’s had 36 years already ?“
====================================== DJT – Again, we get back to, when the clinical trial is finished, not when Burzynski started
====================================== BB – “Treating people”
====================================== DJT – I mean, you would expect to find a results to be published after, the final results are in
====================================== BB – “You would expect the Burzynski Patient Group to be a lot bigger after 36 years, and in fact is
====================================== DJT – You would expect some people would want to have confidentiality, and maybe not want to be included
====================================== BB – “So, if you’re unsure about this stuff, if you’re unsure about the the time to publication, why are you defending it so hard, other than saying, “I don’t know, I really need to”
====================================== DJT – Why am I unsure ?
====================================== BB – “Uh about the
====================================== DJT – (laughing) I just gave you an example
====================================== BB – “The reasons, the reasons for which that he’s, no, why are you defending him so hard, when you’re unsure ?
—————————————————————— 2:15:02
====================================== DJT – Oh, who said I was unsure ?
I just gave you an example
—————————————————————— Note how Bob ASSUMES that I’m “unsure” when I had the same answer since 0:32:07 [12]
